Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to SÜSS MicroTec on the sale of its subsidiary SUSS MicroOptics to Focuslight Technologies Bryan, Garnier & Co acts as Sole Financial Advisor to Calliditas Therapeutics AB on EUR 92m term loan facility from Athyrium Capital Management Bryan, Garnier & Co acts as Joint Bookrunner on Nikola Corporation’s USD 275m Combined Offering Bryan, Garnier & Co acts as the Sole Financial Advisor to ADIONICS and its shareholders successfully completing $27m Series B led by SQM, a worldwide leading lithium producer Bryan, Garnier & Co acts as Sole Financial Advisor to Seven2 and the Management of Diapason on a secondary LBO led by PSG Equity Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Otovo’s NOK 450 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to Aidon and its majority shareholder Alder on the sale of Aidon to Gridspertise Bryan, Garnier & Co acts as European Lead Manager on Abivax’s USD 236 million Nasdaq IPO Bryan, Garnier & Co acts as Financial Advisor to the Boiron Family in the €875m tender offer for the BOIRON Group, world leader in natural medicine, in partnership with EW Healthcare Partners Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Egetis Therapeutics on a Combined Offering of SEK 462m Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of RTS Group on its sale to Advania Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Nehs Digital and Xperis on their sale to Enovacom
